News Detail
NEW DELHI, 20 SEPT 2020: The Drugs Controller General of India has approved the commercial launch of 'Feluda', the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of Scientific and Industrial Research (CSIR) said on Saturday......
View Details
Source : Zee News
Related News
- Karnataka fails to take action against 1,700 fake doctors (19-04-2024)
- 88 pharma traders face regulatory actions in TN from Jan 1 to April 15 for violation of D&C Act and Rules (19-04-2024)
- US FDA mandates label updates on CAR-T cancer therapies (19-04-2024)
- QR code system enhances drug authentication (19-04-2024)
- SII and University of Oxford Strike Landmark Licensing Agreement for Meningitis-B Vaccine (18-04-2024)
- DCGI informs SLAs antibiotic combo meropenem 1 mg & EDTA for injection has no approval (18-04-2024)
- Gujarat FDCA approved 133 new drug manufacturing units in FY24 (18-04-2024)
- Vaccine reactions in kids have risen over 10 yrs (18-04-2024)
- HC Dismisses Physiotherapists’ Plea Seeking Job as Class-2 Officers (18-04-2024)
- Chhattisgarh Pharmacy Council issued certificates for hundreds of fake pharmacists without verification (18-04-2024)